English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Zenas BioPharma shares fall after phase III data show less efficacy than Amgen’s rival drug
+ Pharmaceuticals
Patient Daily | Jan 14, 2026

Amgen acquires Dark Blue Therapeutics to expand early-stage cancer research
+ Pharmaceuticals
Patient Daily | Jan 14, 2026

GSK and Ionis report positive results for hepatitis B drug candidate
+ Pharmaceuticals
Patient Daily | Jan 14, 2026

Corsera Health raises $80M as lead heart disease drug enters clinical trials
+ Pharmaceuticals
Patient Daily | Jan 14, 2026

Crinetics reports positive mid-stage results for CAH drug as it raises funds
+ Pharmaceuticals
Patient Daily | Jan 14, 2026

Pfizer partners with Cartography Biosciences for new cancer target discovery
+ Pharmaceuticals
Patient Daily | Jan 14, 2026

Jazz Pharmaceuticals reports strong phase III results for Ziihera in stomach cancer trial
+ Pharmaceuticals
Patient Daily | Jan 14, 2026

Deals highlight cancer and neuroscience focus at 2026 J.P. Morgan Healthcare Conference

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation